Gen S, Higashi R, Nagae N, Kigure R, Kamikubo Y, Nobe K
CEN Case Rep. 2025; .
PMID: 39948237
DOI: 10.1007/s13730-025-00974-7.
Miao J, Thongprayoon C, Krisanapan P, Buglioni A, Craici I, Cheungpasitporn W
Kidney Int Rep. 2024; 9(12):3542-3552.
PMID: 39698351
PMC: 11652094.
DOI: 10.1016/j.ekir.2024.09.026.
Baptista A, Macedo A, Marreiros A, Coelho A, Perazella M
J Clin Med. 2024; 13(16).
PMID: 39201010
PMC: 11355908.
DOI: 10.3390/jcm13164869.
Matsuda N, Otsuka H, Kasai R, Otani T, Bollos L, Azane S
Sci Rep. 2024; 14(1):16313.
PMID: 39009630
PMC: 11250846.
DOI: 10.1038/s41598-024-66823-2.
Muhammad A, Zhang Y, Huang L, Yuan Q, Wang W, Pu J
Clin Kidney J. 2024; 17(4):sfae054.
PMID: 38572500
PMC: 10986214.
DOI: 10.1093/ckj/sfae054.
Drug fever: a narrative review.
Someko H, Kataoka Y, Obara T
Ann Clin Epidemiol. 2024; 5(4):95-106.
PMID: 38504950
PMC: 10944987.
DOI: 10.37737/ace.23013.
Acute interstitial nephritis with acute kidney injury after COVID-19 vaccination: a case report.
Lim J, Paek J, Shin H, Park W, Jin K, Choe M
Clin Exp Vaccine Res. 2024; 13(1):68-71.
PMID: 38362370
PMC: 10864883.
DOI: 10.7774/cevr.2024.13.1.68.
Immune checkpoint inhibitors and their interaction with proton pump inhibitors-related interstitial nephritis.
Miao J, Herrmann S
Clin Kidney J. 2023; 16(11):1834-1844.
PMID: 37915905
PMC: 10616479.
DOI: 10.1093/ckj/sfad109.
Changing Tides of Acute Interstitial Nephritis: A Retrospective Observational Study from South India.
Shankar M, Gurusiddaiah S, Mutalik S, Aralapuram K
Indian J Nephrol. 2023; 33(5):362-365.
PMID: 37881735
PMC: 10593296.
DOI: 10.4103/ijn.ijn_142_22.
Acute kidney injury in neurocritical care.
Husain-Syed F, Takeuchi T, Neyra J, Ramirez-Guerrero G, Rosner M, Ronco C
Crit Care. 2023; 27(1):341.
PMID: 37661277
PMC: 10475203.
DOI: 10.1186/s13054-023-04632-1.
Drug induced nephrotoxicity- A mechanistic approach.
Sharma V, Singh T
Mol Biol Rep. 2023; 50(8):6975-6986.
PMID: 37378746
DOI: 10.1007/s11033-023-08573-4.
Clinical Characteristics of Children With Acute Tubulointerstitial Nephritis: A Single-Center Experience.
Leventoglu E, Uzun Kenan B, Buyukkaragoz B, Bakkaloglu S
Cureus. 2023; 15(3):e36379.
PMID: 37090263
PMC: 10115660.
DOI: 10.7759/cureus.36379.
Bland Urine Sediment in a Child with Acute Kidney Injury.
Kundavaram R, Sharma T, Joshi D, Kumar A, Malik S, Bhatt G
J Lab Physicians. 2023; 15(1):152-155.
PMID: 37064964
PMC: 10104720.
DOI: 10.1055/s-0042-1750068.
Biopsy-proven first dose of oxaliplatin-induced acute tubular necrosis leading to end-stage renal failure: a case report.
Soma Y, Kawabe T, Kitaji D, Hoshino K, Sunohara S, Iwano T
BMC Nephrol. 2023; 24(1):76.
PMID: 36978021
PMC: 10052796.
DOI: 10.1186/s12882-023-03116-2.
A Synopsis of Current Theories on Drug-Induced Nephrotoxicity.
Dobrek L
Life (Basel). 2023; 13(2).
PMID: 36836682
PMC: 9960203.
DOI: 10.3390/life13020325.
Usefulness of gallium-67 scintigraphy for evaluating the histopathological activity in interstitial nephritis.
Matsumura M, Okada A, Yokoyama H, Sekiguchi M, Shimizu A, Tanaka T
Clin Exp Nephrol. 2022; 27(3):251-261.
PMID: 36574102
DOI: 10.1007/s10157-022-02302-0.
Filler-Induced Interstitial Nephritis in a Male-to-Female Transgender Person: A Case Report.
Al-Thnaibat M, Mohd A, Mohd O, Ghannam R, Issa M, Sawaqed S
Cureus. 2022; 14(11):e31407.
PMID: 36514666
PMC: 9743912.
DOI: 10.7759/cureus.31407.
Granulomatous interstitial nephritis with CTLA-4 haploinsufficiency: a case report.
Kohatsu K, Suzuki T, Takimoto M, Matsui K, Hashiguchi A, Koike J
BMC Nephrol. 2022; 23(1):367.
PMID: 36384506
PMC: 9670605.
DOI: 10.1186/s12882-022-02999-x.
Valproic-induced Fanconi syndrome: Clinical features, risk factors, diagnosis and management.
Wang C, Zhou Y, Song L, Deng Z, Fang W
Front Med (Lausanne). 2022; 9:945244.
PMID: 36186816
PMC: 9522966.
DOI: 10.3389/fmed.2022.945244.
Ten Cases of Biopsy-Proven Acute Tubulointerstitial Nephritis: Report from a Single Center in a Rural Area from 2008 to 2021.
Nagai K, Tsukada T, Sakata A, Ueda A
Case Rep Nephrol. 2022; 2022:6203803.
PMID: 36032631
PMC: 9411007.
DOI: 10.1155/2022/6203803.
